The US Food and Drug Administration has sent warning letters to 13 molecular diagnostic companies as part of its bid to improve the regulation of genetic testing1.
The agency has targeted firms selling genetic tests directly to consumers, including Interleukin Health, CyGene Direct, Consumer Genetics and Sequenom...
Please login to read the full article.
